Tropanserin
Chemical compound
From Wikipedia, the free encyclopedia
Tropanserin (INN; MDL-72,422) is a drug which acts as a potent and selective 5-HT3 receptor antagonist.[1] It was investigated in clinical trials for the treatment of migraine in the 1980s but was never marketed.[2]
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H23NO2 |
| Molar mass | 273.376 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Synthesis
Tropanserin can be prepared by the reaction of tropine with 3,5-dimethylbenzoyl chloride, releasing hydrogen chloride.
